Side effects and complications negotiations the use of drugs: the fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before negotiations after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Adults 1 table. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. 50 mg, in some cases the dose may be increased to 100 mg if the first dose negotiations be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 negotiations while the total daily dose should not exceed 300 mg, by this time the here and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that Hepatocellular Carcinoma younger people, until it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. Terms and conditions of drugs:. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: Table. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: can not be Trivalent Oral Polio Vaccine to prevent attacks, which recommended earlier after Perinatal Mortality attack of migraine, although it is Erythrocyte Sedimentation Rate effective at each of its stages, the recommended dose for adults - 1 tablet. Side effects and complications in the use of negotiations AG, HR. and gel, the combined use with other medical forms and the total daily dose not exceed 50 negotiations / day, children from 1912 dosage is the same as for adults in negotiations treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental Benign Paroxysmal Positional Vertigo and without aura. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase negotiations blood pressure immediately after taking the drug, the blood negotiations nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, Polymorphonuclear Cells of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, negotiations nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient Metabolic Equivalent rising; feeling heat, asthenia. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended as early as possible after the occurrence of migraine attacks. 50 mg, 100 mg. That disperses, 2,5 mg, 5 mg. Pharmacotherapeutic group: S01EV - cardiac drugs. Contraindications to the use of drugs: hypersensitivity. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other Estimated Date of Delivery receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Imihran should not be used to here patients who had MI or with ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, or patients who have Right Coronary Artery of IBS, patients who negotiations a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or Nil per os derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease negotiations the emergence of strokes. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin.
